Skip to main content
Earnings Labs
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc. (STRO)

NASDAQ·Healthcare·Biotechnology

$15.63

-3.13%

Mkt Cap $290.22M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (19 analysts)

$51.00

Range $43.00$60.00

Implied Upside

+226.4%

Consensus $51.00 vs current $15.63